000			01543 a2200457 4500
005			20250514190814.0
264		0	_c20071107
008			200711s 0 0 eng d
022			_a1534-6269
024	7		_a10.1007/s11912-004-0033-2 _2doi
040			_aNLM _beng _cNLM
100	1		_aStabile, Laura P
245	0	0	_aEstrogen receptor pathways in lung cancer. _h[electronic resource]
260			_bCurrent oncology reports _cJul 2004
300			_a259-67 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Review
650	0	4	_aAge Factors
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Agents _xtherapeutic use
650	0	4	_aEpidermal Growth Factor _xmetabolism
650	0	4	_aEstrogen Receptor alpha _xmetabolism
650	0	4	_aEstrogen Receptor beta _xmetabolism
650	0	4	_aEstrogens _xadverse effects
650	0	4	_aFemale
650	0	4	_aGefitinib
650	0	4	_aHumans
650	0	4	_aLung Neoplasms _xepidemiology
650	0	4	_aMale
650	0	4	_aQuinazolines _xtherapeutic use
650	0	4	_aReceptors, Estrogen _xbiosynthesis
650	0	4	_aRisk Factors
650	0	4	_aSex Distribution
650	0	4	_aSex Factors
650	0	4	_aSignal Transduction
650	0	4	_aSmoking _xadverse effects
650	0	4	_aSurvival Rate
650	0	4	_aUnited States _xepidemiology
700	1		_aSiegfried, Jill M
773	0		_tCurrent oncology reports _gvol. 6 _gno. 4 _gp. 259-67
856	4	0	_uhttps://doi.org/10.1007/s11912-004-0033-2 _zAvailable from publisher's website
999			_c14869966 _d14869966